“next-generation sequencing (ngs) global market – forecast to 2022”

IQ4I Research & Consultancy Pvt. Ltd.

Next-Generation Sequencing (NGS) Global Market

–Forecast to 2022

Next-generation Sequencing (NGS) Global Market estimated to be worth $14,722.5 million by 2022 IQ4I Research & Consultancy published a new report on “Next-Generation

Sequencing (NGS) Global Market – Forecast To 2022” This report analyzes and studies

the overall market, major drivers & Opportunities, Restraints & Threats in North America,

Europe, Asia-Pacific and Rest of the World

IQ4I’s Report Contains 112 market data tables and 69 figures spread through 375

pages and an exhaustive TOC on “Next-Generation Sequencing (NGS) Global

Market [Technology (Reversible terminator Sequencing, Ion-Semiconductor sequencing,

Sequencing by Ligation, Single-Molecule Real-time (SMRT) Sequencing and others),

Products (Instruments, Services and Work-flow products), , Application (By Process and By

field) (By Process- Genomics, Epigenomics, Transcriptomics and Others & By field-

Diagnostics, Drug discovery and development, Biomarker discovery, Agriculture and

animal research and Others), End-Users (Academic Research, Hospitals and clinics,

Biotech/Pharmaceuticals and Others) Region [(North America (U.S. and Others), Europe

(U.K., Germany, Spain and Others), APAC(South Korea, China, Australia and others) and

ROW(Brazil, South Africa, Middle East and Others)]

This report analyzes the Next-Generation Sequencing global market in terms of market

revenue ($ million) for all segments and it enables Next-Generation Sequencing

stakeholders such as NGS service providers, diagnostic testing and monitoring service

centers, clinical laboratories & hospitals, pharma & biotech Companies, Various research

and consulting firms to identify and analyze market expansion opportunities, technological

advancements and competition in Next-Generation Sequencing global market.

Next-generation sequencing refers to modern non-Sanger-based high-throughput DNA

sequencing technologies that can sequence millions or billions of DNA strands in parallel,

yielding substantially more throughput and minimizing the need for the time consuming

fragment-cloning methods that are often used in Sanger sequencing of genomes. Next-

generation sequencing market is a fast emerging market with a high growth rate, as

estimated by IQ4I Research that the Next-generation sequencing global market are

expected to grow at a high double-digit CAGR from 2015-2022.

Reduced cost and high speed of NGS technology, increased usage in the clinical segment,

new application areas of NGS and switch over from microarrays to NGS, are expected to

propel the growth of next-generation sequencing market. However some issues like

standardization of NGS for clinical use, complexity in data interpretation, shortage of skilled



–Forecast to 2022

labor and dependence on grants and funding for NGS infrastructure may hinder the growth

of next-generation sequencing market.

The Next-generation sequencing global market by technology is segmented into Reversible

terminator sequencing, Ion semi-conductor sequencing, Sequencing by Ligation (SBL),

Single-Molecule Real-time (SMRT) Sequencing and others. The Reversible terminator

sequencing occupied highest market in Next-generation sequencing technology market. The

Next-generation sequencing global market by products is segmented into Instruments,

Services and Work-flow products. The services market is further segmented into Data

analysis services and Sequencing Services. The Services segment is estimated to grow at

strong CAGR from 2015 to 2022.

The Next-generation sequencing global market by Application is segmented based on

process and field of application. By process, the market is segmented into Genomics,

Epigenomics, Transcriptomics and others. Genomics application is further segmented into

Whole genome sequencing, Exome sequencing, Targeted sequencing and De Novo

sequencing). Epigenomics market is further segmented into ChiP sequencing and

Methylation sequencing). By field of application, the market is segmented into Diagnostics,

Drug discovery and development, Biomarker discovery, Agriculture and animal research and

others. Diagnostics application is further segmented into Cancer diagnostics, Infectious

disease diagnostics, Genetic analysis and Transplantation diagnostics. The Diagnostics

application occupied highest market in Next-generation sequencing application market. The

End-users consists of Academic Research, Hospitals and clinics, Biotech/Pharmaceuticals

and Others. The Academic Research contributed the largest revenue as per estimates of

IQ4I Research.

The Next-generation sequencing global market based on geography is divided into North

America, Europe, Asia-Pacific and Rest of the world. North American region commanded the

largest revenue in 2015 due to advanced technological healthcare framework, rise in growth

of personalized medicine, increasing incidence of infectious disease and cancer, high R&D

investment for genomic and proteomic sequence determination for biomarker and drug

discovery research.

Some of the prominent players in next-generation sequencing market include Agilent

Technologies (U.S.), BGI (China), Illumina, Inc. (U.S.), Pacific Biosciences of California, Inc.

(U.S.), Qiagen N.V. (Netherlands), Oxford Nanopore Technologies Ltd. (U.K.), Eurofins



–Forecast to 2022

Scientific (U.K.), Roche holdings AG (Switzerland), DNASTAR, Inc. (U.S.), Thermo Fischer

Scientific, Inc.(U.S).

Reasons for buying this report:

Analysis of the Next-generation sequencing global market by identifying various

segments by technology, product type, applications, end users and geography.

Revenue forecast of the Next-generation sequencing market and strategic analysis of

each submarket with respect to segmental growth trends.

Analysis of the major market trends and factors driving or inhibiting the growth of the

Next-generation sequencing global market.

Revenue forecast of the NGS market with respect to North America (U.S. and

others), Europe (U.K., Germany, Spain and Others), Asia-Pacific (China, South

Korea, Australia and others) and the Rest of the World (RoW) (Brazil, Middle East,

South Africa and Others).

Analysis of the opportunities for stakeholders by identifying the high-growth

segments of the market.

Analysis of country wise installation base.

Identification of key technology developments and innovations driving the market.

Profiles of major players in the next-generation sequencing global market with details

of their product offerings, business strategies, market shares and patent application

filing trends.

Established and Emerging players (47 companies) and their product offerings.



–Forecast to 2022

FIGURE 1

NEXT-GENERATION SEQUENING GLOBAL MARKET SEGMENTATION


By Technique

Reversible Terminator

Sequencing

By Product By End-Users

Ion Semiconductor

sequencing

Sequencing by

Ligation

Instruments

Work flow products

Academic

research

Hospitals

Biotech/Pharma

SMRT Sequencing

Others

Services

Data Analysis

Services

Sequencing

Services

By Application

By processBy Field

Diagnostics

Drug Discovery &

Development

Biomarker

discovery

Agriculture & animal

health

Others

Epigenomics

Genomics

Transcriptomics

Others

Cancer diagnostics

Transplant dgx

Genetic analysis

Infectious diseases

WGS

Targeted sequencing

Exome sequencing

De-novo sequencing

Methyl sequencing

ChIP Sequencing

Others

“next-generation sequencing (ngs) global market – forecast to 2022”

Healthcare